519
In e na ional Jou nal o Ad ance and Applied Resea ch
www.ijaa .co.in
ISSN – 2347-7075
Impac Fac o – 8.141
Pee Re iewed
Bi-Mon hly
Vol. 6 No. 40
Sep embe - Oc obe - 2025
Pha macognosy: A Comp ehensi e S udy o Na u al Sou ces o D ugs and
Thei Applica ions in Mode n Medicine
Ashok N. Naga goje
Depa men o Chemis y,
M s. Kesha bai Sonaji ao Kshi saga College Beed Dis . Beed, India
Co esponding Au ho – Ashok N. Naga goje
DOI - 10.5281/zenodo.17663932
Abs ac :
Pha macognosy, a i al b anch o pha maceu ical sciences, is he s udy o bioac i e na u al
p oduc s ob ained om plan s, animals, and mic oo ganisms. I encompasses he iden i ica ion,
ex ac ion, isola ion, and analysis o na u al subs ances wi h he apeu ic po en ial. Pha macognosy
b idges adi ional medicine and mode n d ug disco e y, con ibu ing signi ican ly o
pha maceu icals such as alkaloids, an ibio ics, and an icance agen s. This pape explo es he
his o y, scope, me hodologies, phy ochemical aspec s, he apeu ic applica ions, challenges, and
u u e di ec ions o pha macognosy.
In oduc ion:
Pha macognosy is a b anch o
pha maceu ical sciences ha deals wi h he
s udy o c ude d ugs ob ained om na u al
sou ces such as plan s, animals,
mic oo ganisms, and mine als. The wo d
pha macognosy is de i ed om wo G eek
wo ds: “pha makon” meaning d ug, and
“gnosis” meaning knowledge. Thus,
pha macognosy li e ally means “knowledge o
d ugs.”
I is one o he oldes b anches o
pha macy and medicine, acing back o
ancien ci iliza ions such as Ayu eda in
India, T adi ional Chinese Medicine, and
Egyp ian medicine, whe e he bs, mine als, and
animal p oduc s we e used o healing
pu poses. O e ime, wi h he disco e y o
ac i e chemical cons i uen s such as mo phine
( om Papa e somni e um), quinine ( om
Cinchona ba k), and penicillin ( om
Penicillium ungi), pha macognosy e ol ed
in o a scien i ic discipline.
In mode n imes, pha macognosy no
only ocuses on he iden i ica ion,
au hen ica ion, ex ac ion, and isola ion o
na u al p oduc s, bu also on unde s anding
hei chemical s uc u es, pha macological
ac i i ies, and he apeu ic applica ions. I plays
a key ole in d ug disco e y, nu aceu ical
de elopmen , cosme ic o mula ions, and
al e na i e medicine.
Pha macognosy se es as a b idge
be ween adi ional medicine and mode n
pha maceu ical esea ch, ensu ing he
s anda diza ion, sa e y, and e icacy o na u al
p oduc s. Wi h inc easing global in e es in
he bal medicines, na u al supplemen s, and
biologically ac i e compounds,
pha macognosy con inues o be an essen ial
ield o he de elopmen o sa e and e ec i e
he apeu ic agen s
IJAAR Vol. 6 No. 40 ISSN – 2347-7075
Ashok N. Naga goje
520
His o y o Pha macognosy:
a) Ancien E a: Use o he bs in Ayu eda
(Cha aka Samhi a, Sush u a Samhi a)
and T adi ional Chinese Medicine.
b) Middle Ages: Con ibu ions om
Islamic schola s (A icenna’s Canon o
Medicine).
c) 18 h–19 h Cen u y: Isola ion o pu e
compounds like mo phine (1805),
quinine (1820).
d) Mode n E a: In oduc ion o ad anced
analy ical echniques, molecula
biology, and bio echnology o d ug
de elopmen .
Scope o Pha macognosy:
a) Iden i ica ion & Au hen ica ion o
c ude d ugs.
b) Phy ochemis y: Isola ion and
cha ac e iza ion o plan me aboli es.
c) Pha macology & Toxicology:
E alua ing he apeu ic e icacy and
sa e y.
d) Bio echnology: Gene ic enginee ing o
enhanced me aboli e p oduc ion.
e) D ug Disco e y: De elopmen o no el
d ugs om na u al sou ces.
Sou ces o D ugs in Pha macognosy:
a) Plan Sou ces: Alkaloids (mo phine,
a opine), e penoids (a emisinin,
axol), glycosides (digoxin).
b) Animal Sou ces: Insulin, cod li e oil,
hepa in.
c) Mic obial Sou ces: Penicillin,
s ep omycin, e acyclines.
d) Ma ine Sou ces: Cy a abine
(an icance ), zicono ide (analgesic).
e) Mine al Sou ces: Sul u , kaolin,
magnesium sul a e.
Ex ac ion and Isola ion Techniques:
T adi ional me hods: In usion,
decoc ion, pe cola ion, Soxhle
ex ac ion.
Mode n echniques:
Supe c i ical luid ex ac ion (CO₂
ex ac ion).
Mic owa e-assis ed ex ac ion.
Ul asonica ion.
Ch oma og aphic echniques (HPLC,
GC-MS, LC-MS).
Cha ac e iza ion ools: Spec oscopy
(NMR, IR, UV-Vis), Mass
spec ome y, X- ay c ys allog aphy.
Phy ochemicals and Thei Impo ance:
A) Alkaloids:
Alkaloids a e a la ge g oup o
na u ally occu ing o ganic compounds ha
con ain ni ogen a oms, usually in a
he e ocyclic ing. They a e mos ly de i ed
om plan s bu can also be ob ained om
animals, ungi, and mic oo ganisms. Alkaloids
a e well known o hei s ong physiological
e ec s on humans and animals, making hem
impo an in medicine and pha macology.
a) Analgesics: Mo phine (Papa e
somni e um).
b) An imala ial: Quinine (Cinchona
ba k).
c) S imulan s: Ca eine (Co ea a abica),
Nico ine (Nico iana abacum).
d) An ihype ensi e: Rese pine
(Rauwol ia se pen ina).
e) B onchodila o : Ephed ine (Ephed a
species).
) Local Anes he ic: Cocaine
(E y h oxylum coca)
B) Fla onoids & Phenolics:
Phenolics a e a la ge class o na u ally
occu ing compounds cha ac e ized by
IJAAR Vol. 6 No. 40 ISSN – 2347-7075
Ashok N. Naga goje
521
one o mo e hyd oxyl g oups a ached
di ec ly o an a oma ic ing.
Fla onoids a e a subg oup o
polyphenolic compounds wi h a gene al
s uc u e o C6-C3-C6 ( wo a oma ic
ings connec ed by a h ee-ca bon
b idge). Bo h a e widely dis ibu ed in
he plan kingdom and play an essen ial
ole in plan de ense, pigmen a ion,
and human heal h
a) An ioxidan : Que ce in, Res e a ol –
sca enge ee adicals, educe oxida i e
s ess.
b) Ca diop o ec i e: Fla onoids in ed
wine ( es e a ol) imp o e hea heal h.
c) An i-in lamma o y: Apigenin,
Lu eolin educe in lamma ion
media o s.
d) An icance : Ca echins in g een ea
inhibi umo g ow h.
e) Hepa op o ec i e: Silyma in ( om
milk his le).
) Neu op o ec i e: Cu cumin (a
polyphenol) imp o es cogni i e
unc ion.
g) An imic obial: Phenolic acids like
gallic acid and ca eic acid
C) Te penoids:
Te penoids (also called isop enoids)
a e a la ge and di e se class o na u ally
occu ing o ganic compounds de i ed om
i e-ca bon isop ene (C₅H₈) uni s. They a e
ound mainly in plan s, ungi, and some
ma ine o ganisms. Te penoids a e esponsible
o he a oma, la o , and pigmen s o many
plan s and also exhibi impo an
pha macological ac i i ies.
a) An imala ial: A emisinin (A emisia
annua).
b) An icance : Pacli axel (Taxol) om
yew ee.
c) An i-in lamma o y: Boswellic acids
( om Boswellia se a a / ankincense).
d) An imic obial: Thymol, Men hol
(essen ial oils).
e) An ioxidan & Vi amin sou ce: β-
Ca o ene (p o i amin A).
) Ca diop o ec i e: Ginkgolides ( om
Ginkgo biloba).
g) Hepa op o ec i e: Silyma in ( hough
pa ly la onolignans, con ains
e penoid elemen s
D) Glycosides:
Glycosides a e na u ally occu ing
compounds in which a suga po ion (glycone)
is bound o a non-suga po ion (aglycone o
genin) h ough a glycosidic bond. The suga
pa inc eases solubili y, while he aglycone
pa de e mines he pha macological ac i i y.
They a e widely dis ibu ed in plan s and play
an impo an ole in plan de ense and
me abolism
a. Ca dio onic: Digoxin, Digi oxin
(Digi alis) used in conges i e hea
ailu e.
b. Laxa i es: Sennosides (Senna), Aloe
glycosides (Aloe e a).
c. An i-in lamma o y & An i ussi e:
Glycy hizin (Lico ice).
d. Con acep i e p ecu so : Diosgenin
(Diosco ea).
e. An i-cance : Amygdalin (Lae ile;
hough con o e sial).
. An imic obial & s imulan : Sinig in
(mus a d oil)
E) Tannins & Resins:
Tannins a e a g oup o high-molecula -
weigh , wa e -soluble, polyphenolic
compounds widely dis ibu ed in plan s.
They ha e he abili y o p ecipi a e
p o eins and alkaloids, which is why
hey a e used in anning lea he (hence
IJAAR Vol. 6 No. 40 ISSN – 2347-7075
Ashok N. Naga goje
522
he name). Tannins also play an
impo an ole in plan de ense and
human heal h.
a. As ingen : Used in dia hea (Ka ha
om Acacia ca echu).
b. An ioxidan : Ca echins in g een ea.
c. An imic obial: Tannins in
pomeg ana e peel.
d. An icance : P oan hocyanidins in
g ape seed ex ac .
e. Wound healing: Tannins in wi ch
hazel.
Resins a e amo phous, solid o semi-
solid, complex mix u es o ola ile
oils, e penoids, and o he compounds,
sec e ed by specialized plan cells
(mainly in coni e s). They a e
insoluble in wa e bu soluble in
o ganic sol en s.
a. An isep ic & an i-in lamma o y:
Benzoin esin (used in inc u e o
benzoin).
b. An ispasmodic: Asa oe ida (oleo-
gum- esin).
c. Laxa i e: Jalap esin (Ipomoea
pu ga).
d. Analgesic & psychoac i e: Cannabis
esin (hashish).
e. Ca mina i e & expec o an :
Tu pen ine.
Applica ions o Pha macognosy:
D ug Disco e y: Mo phine,
inc is ine, a emisinin.
Nu aceu icals: He bal supplemen s,
an ioxidan s.
Cosme ics: Aloe e a, neem, u me ic
in skinca e.
Ve e ina y Medicine: He bal
emedies o li es ock.
Bio echnology: Plan issue cul u e
o seconda y me aboli e p oduc ion.
Challenges in Pha macognosy:
a) O e exploi a ion and ex inc ion o
medicinal plan s.
b) S anda diza ion and quali y con ol
issues.
c) Low yields o ac i e cons i uen s.
d) Pa en and in ellec ual p ope y igh s
(IPR) conce ns.
e) De elopmen o esis ance o na u al
an imic obials.
Fu u e Pe spec i es:
Bio echnology & Genomics: Use o
gene ic enginee ing o me aboli e
p oduc ion.
Nano echnology: Imp o ed deli e y
o na u al d ugs.
E hnopha macology: In eg a ion o
adi ional knowledge wi h mode n
science.
Sus ainable Use: Cul i a ion and
conse a ion o medicinal plan s.
A i icial In elligence: AI-d i en
d ug disco e y om na u al
compound da abases.
Conclusion:
Pha macognosy emains a he hea o
d ug disco e y and de elopmen . F om
ancien he bal emedies o mode n
pha maceu icals, na u al p oduc s con inue o
p o ide s uc u ally di e se and
pha macologically po en agen s. Wi h
ad ances in bio echnology, nanoscience, and
compu a ional biology, pha macognosy holds
immense po en ial o he de elopmen o sa e,
e ec i e, and sus ainable he apeu ic agen s in
he u u e.
IJAAR Vol. 6 No. 40 ISSN – 2347-7075
Ashok N. Naga goje
523
Re e ences:
1. Koka e, C.K., Pu ohi , A.P., &
Gokhale, S.B. (2017).
Pha macognosy. Ni ali P akashan.
2. T ease, G.E., & E ans, W.C. (2009).
Pha macognosy (16 h Edi ion).
Saunde s Else ie .
3. Hein ich, M., Ba nes, J., Gibbons, S.,
& Williamson, E.M. (2012).
Fundamen als o Pha macognosy and
Phy o he apy. Chu chill Li ings one.
4. Newman, D.J., & C agg, G.M. (2020).
Na u al P oduc s in D ug Disco e y
and De elopmen . Jou nal o Na u al
P oduc s, 83(3), 770–803
